Accurate, balanced evidence-based information about medicines
Browse our health professional information, resources and educational activities on attention deficit hyperactivity disorder (ADHD) drugs.

| Title | Description | Content type | Date* |
|---|---|---|---|
| Atomoxetine (Strattera) for attention deficit hyperactivity disorder | Reviews use of atomoxetine for ADHD in children, adolescents, and adults, and compares atomoxetine with methylphenidate, dexamphetamine, and other psychostimulants. | NPS RADAR>Review>Health Professional Publication | 2007-07-01 00:00:00 |
| Methylphenidate (Ritalin) for attention deficit hyperactivity disorder | Reviews use of methylphenidate for attention deficit hyperactivity disorder, including drug control issues and combination with non-drug interventions. | NPS RADAR>Review>Health Professional Publication | 2005-08-01 00:00:00 |
| Methylphenidate (Ritalin LA): a second controlled-release formulation PBS listed for attention deficit hyperactivity disorder | A second controlled-release formulation of methylphenidate (Ritalin LA) was listed on the PBS to be prescribed for patients aged 6 to 18 years inclusive for attention deficit hyperactivity disorder (ADHD). | NPS RADAR>Brief Item>Health Professional Publication | 2008-04-01 00:00:00 |
| Methylphenidate extended-release (Concerta) for attention deficit hyperactivity disorder (ADHD) | Reviews use of extended-release methylphenidate, including comparison with immediate-release formulation and risk of cardiovascular adverse effects. | NPS RADAR>Review>Health Professional Publication | 2007-02-01 00:00:00 |


| Content type | Date* | Title |
|---|---|---|
| Australian Prescriber - Article | 1995-08-01 00:00:00 | Stimulant treatment for attention deficit hyperactivity disorder |
| Australian Prescriber - Article | 1995-08-01 00:00:00 | Stimulant treatment for ADHD: a comment |

* Information current at date of publication.